
    
      This is a single-center, randomized, double-blinded, placebo- and moxifloxacin-controlled, 3
      period, 6-sequence, 3 treatment (venlafaxine and placebo blinded; moxifloxacin open label),
      3-way crossover thorough QT (TQT) study of the effects of venlafaxine on cardiac
      repolarization in approximately 54 healthy subjects
    
  